Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
104.91
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
November 23, 2025
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers.
Via
StockStory
Topics
Artificial Intelligence
Halper Sadeh LLC Encourages EXAS, NVRI, MRUS Shareholders to Contact the Firm to Discuss Their Rights
November 22, 2025
Shareholders should contact the firm immediately as there may be limited time to enforce your rights
From
Halper Sadeh LLC
Via
GlobeNewswire
Exact Sciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Exact Sciences Corporation - EXAS
November 21, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits
↗
November 20, 2025
Via
Stocktwits
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More
↗
November 20, 2025
On a big day for tech stocks, some other less well-known companies saw even larger moves.
Via
The Motley Fool
Topics
Artificial Intelligence
Stocks
Why Exact Sciences Rallied Over 50% This Week
↗
November 20, 2025
The company received a buyout offer from Abbot Labs.
Via
The Motley Fool
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Exact Sciences Corporation (Nasdaq – EXAS)
November 20, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover
↗
November 20, 2025
Via
Stocktwits
Why Exact Sciences Stock Surged Today
↗
November 20, 2025
A healthcare giant covets the cancer screening leader's technology.
Via
The Motley Fool
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday?
↗
November 20, 2025
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday.
Via
Benzinga
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday
↗
November 20, 2025
Via
Benzinga
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics
↗
November 20, 2025
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum.
Via
Benzinga
EXAS Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Exact Sciences Corporation is Fair to Shareholders
November 20, 2025
From
Halper Sadeh LLC
Via
Business Wire
Abbott To Acquire Exact Sciences For Up To $23B
↗
November 20, 2025
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash.
Via
Stocktwits
Why Exact Sciences Stock Blasted Nearly 24% Higher Today
↗
November 19, 2025
A strategic investor is reportedly in advanced talks to purchase the company.
Via
The Motley Fool
2 Surging Stocks with Competitive Advantages and 1 We Question
November 16, 2025
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...
Via
StockStory
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
November 10, 2025
From
Exact Sciences Corp.
Via
Business Wire
The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call
November 10, 2025
Exact Sciences’ third quarter results received a positive response from the market, reflecting strong revenue growth and robust execution in its core screening business. Management attributed the...
Via
StockStory
Topics
Earnings
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term
↗
November 08, 2025
These companies are slowly coming into their own.
Via
The Motley Fool
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
November 07, 2025
From
Exact Sciences Corp.
Via
Business Wire
Why Exact Sciences Stock Blasted Higher on Tuesday
↗
November 04, 2025
An impressive beat-and-raise third quarter made the company a standout that day.
Via
The Motley Fool
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results
↗
November 04, 2025
Via
Benzinga
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday?
↗
November 04, 2025
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date...
Via
Benzinga
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
November 04, 2025
Via
Benzinga
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
November 04, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...
Via
StockStory
Exact Sciences to Participate in November Investor Conference
November 04, 2025
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
↗
November 03, 2025
Exact Sciences (EXAS) Q3 2025 Earnings Transcript
Via
The Motley Fool
Topics
Earnings
Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars
November 03, 2025
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year...
Via
StockStory
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat
↗
November 03, 2025
Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide.
Via
Investor's Business Daily
Topics
Earnings
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 03, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
22
23
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
